|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York State Psychiatric Institute |
|---|---|
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000269 |
Purpose
The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.
| Condition | Intervention | Phase |
|---|---|---|
|
Cocaine-Related Disorders Substance-Related Disorders |
Drug: Pergolide |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Pergolide Treatment for Substance Abusers |
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations| United States, New York | |
| New York State Psychiatric Institute | |
| New York, New York, United States, 10032 | |
| Principal Investigator: | Herbert Kleber, M.D. | New York State Psychiatric Institute |
More Information
| Study ID Numbers: | NIDA-09236-4, P50-09236-4 |
| Study First Received: | September 20, 1999 |
| Last Updated: | August 16, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000269 |
| Health Authority: | United States: Federal Government |
|
Cocaine-Related Disorders Dopamine Mental Disorders |
Substance-Related Disorders Disorders of Environmental Origin Pergolide |
|
Neurotransmitter Agents Pathologic Processes Disease Molecular Mechanisms of Pharmacological Action |
Physiological Effects of Drugs Dopamine Agents Dopamine Agonists Pharmacologic Actions |
